Targeting multiple signal transduction pathways of SARS-CoV-2: Approaches to COVID-19 therapeutic candidates
Due to the complicated pathogenic pathways of coronavirus disease 2019 (COVID-19),
related medicinal therapies have remained a clinical challenge. COVID-19 highlights the …
related medicinal therapies have remained a clinical challenge. COVID-19 highlights the …
Emerging molecular prospective of SARS-CoV-2: Feasible nanotechnology based detection and inhibition
S Patra, RG Kerry, GK Maurya, B Panigrahi… - Frontiers in …, 2020 - frontiersin.org
The rapid dissemination of SARS-CoV-2 demonstrates how vulnerable it can make
communities and is why it has attained the status of global pandemic. According to the …
communities and is why it has attained the status of global pandemic. According to the …
Application of nanomaterials as an advanced strategy for the diagnosis, prevention, and treatment of viral diseases
The coronavirus disease (COVID-19) pandemic poses serious global health concerns with
the continued emergence of new variants. The periodic outbreak of novel emerging and re …
the continued emergence of new variants. The periodic outbreak of novel emerging and re …
COVID-19 outbreak and emerging management through pharmaceutical therapeutic strategy
The latest SARS COV2 coronavirus contributes to a pandemic of millions of COVID-19. As
there is no defensive immunity in humans and a virus can overcome inborn immune …
there is no defensive immunity in humans and a virus can overcome inborn immune …
Nanomaterials to combat SARS-CoV-2: Strategies to prevent, diagnose and treat COVID-19
A Valenzuela-Fernández… - … in Bioengineering and …, 2022 - frontiersin.org
The severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) infection and the
associated coronavirus disease 2019 (COVID-19), which severely affect the respiratory …
associated coronavirus disease 2019 (COVID-19), which severely affect the respiratory …
Nanotechnology-based approaches and investigational therapeutics against COVID-19
Severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) is the novel coronavirus
responsible for the current global pandemic, which first emerged in December 2019. This …
responsible for the current global pandemic, which first emerged in December 2019. This …
Advancements of nanotechnology and nanomaterials in environmental and human protection for combatting the covid-19 during and post-pandemic era: a …
In December 2019, an outbreak of unknown pneumonia emerged in Wuhan City, Hubei
Province, China. It was later identified as the SARS-CoV-2 virus and has since infected over …
Province, China. It was later identified as the SARS-CoV-2 virus and has since infected over …
The potential role of nanomedicine on COVID-19 therapeutics
RM Mainardes, C Diedrich - Therapeutic Delivery, 2020 - Taylor & Francis
Conclusion To date, there are no specific approved drugs for treating SARS-CoV-2, and
vaccines are under clinical trials. All efforts are welcome to combat the virus, and nanotech …
vaccines are under clinical trials. All efforts are welcome to combat the virus, and nanotech …
Current landscape of natural products against coronaviruses: Perspectives in COVID-19 treatment and anti-viral mechanism
Background: SARS-CoV-2 is a coronavirus, and the infection by SARS-CoV-2, termed as
COVID-19, was first reported in Wuhan, China, at the end of 2019, and this outbreak became …
COVID-19, was first reported in Wuhan, China, at the end of 2019, and this outbreak became …
Nanomedicine as a promising approach for diagnosis, treatment and prophylaxis against COVID-19
NH Abd Ellah, SF Gad, K Muhammad, GE Batiha… - …, 2020 - Taylor & Francis
The COVID-19 pandemic caused by the newly emerged severe acute respiratory syndrome
coronavirus-2 (SARS-CoV-2) puts the world in an unprecedented crisis, leaving behind …
coronavirus-2 (SARS-CoV-2) puts the world in an unprecedented crisis, leaving behind …